Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Aug;92(2):791–798. doi: 10.1172/JCI116652

Fatty acids are required for epidermal permeability barrier function.

M Mao-Qiang 1, P M Elias 1, K R Feingold 1
PMCID: PMC294916  PMID: 8102380

Abstract

The permeability barrier is mediated by a mixture of ceramides, sterols, and free fatty acids arranged as extracellular lamellar bilayers in the stratum corneum. Whereas prior studies have shown that cholesterol and ceramides are required for normal barrier function, definitive evidence for the importance of nonessential fatty acids is not available. To determine whether epidermal fatty acid synthesis also is required for barrier homeostasis, we applied 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA), an inhibitor of acetyl CoA carboxylase, after disruption of the barrier by acetone or tape stripping. TOFA inhibits epidermal fatty acid by approximately 50% and significantly delays barrier recovery. Moreover, coadministration of palmitate with TOFA normalizes barrier recovery, indicating that the delay is due to a deficiency in bulk fatty acids. Furthermore, TOFA treatment also delays the return of lipids to the stratum corneum and results in abnormalities in the structure of lamellar bodies, the organelle which delivers lipid to the stratum corneum. In addition, the organization of secreted lamellar body material into lamellar bilayers within the stratum corneum interstices is disrupted by TOFA treatment. Finally, these abnormalities in lamellar body and stratum corneum membrane structure are corrected by coapplication of palmitate with TOFA. These results demonstrate a requirement for bulk fatty acids in barrier homeostasis. Thus, inhibiting the epidermal synthesis of any of the three key lipids that form the extracellular, lipid-enriched membranes of the stratum corneum results in an impairment in barrier homeostasis.

Full text

PDF
791

Images in this article

795Image
on p.795
796Image
on p.796
796Image
on p.796

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Elias P. M., Friend D. S., Goerke J. Membrane sterol heterogeneity. Freeze-fracture detection with saponins and filipin. J Histochem Cytochem. 1979 Sep;27(9):1247–1260. doi: 10.1177/27.9.479568. [DOI] [PubMed] [Google Scholar]
  2. Elias P. M., Menon G. K. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res. 1991;24:1–26. doi: 10.1016/b978-0-12-024924-4.50005-5. [DOI] [PubMed] [Google Scholar]
  3. Feingold K. R., Man M. Q., Menon G. K., Cho S. S., Brown B. E., Elias P. M. Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest. 1990 Nov;86(5):1738–1745. doi: 10.1172/JCI114899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Feingold K. R. The regulation and role of epidermal lipid synthesis. Adv Lipid Res. 1991;24:57–82. doi: 10.1016/b978-0-12-024924-4.50007-9. [DOI] [PubMed] [Google Scholar]
  5. Fukuda N., Ontko J. A. Interactions between fatty acid synthesis, oxidation, and esterification in the production of triglyceride-rich lipoproteins by the liver. J Lipid Res. 1984 Aug;25(8):831–842. [PubMed] [Google Scholar]
  6. Grubauer G., Feingold K. R., Elias P. M. Relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res. 1987 Jun;28(6):746–752. [PubMed] [Google Scholar]
  7. Grunfeld C., Gulli R., Moser A. H., Gavin L. A., Feingold K. R. Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res. 1989 Apr;30(4):579–585. [PubMed] [Google Scholar]
  8. Holleran W. M., Feingold K. R., Man M. Q., Gao W. N., Lee J. M., Elias P. M. Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res. 1991 Jul;32(7):1151–1158. [PubMed] [Google Scholar]
  9. Holleran W. M., Man M. Q., Gao W. N., Menon G. K., Elias P. M., Feingold K. R. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest. 1991 Oct;88(4):1338–1345. doi: 10.1172/JCI115439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hou S. Y., Mitra A. K., White S. H., Menon G. K., Ghadially R., Elias P. M. Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction. J Invest Dermatol. 1991 Feb;96(2):215–223. doi: 10.1111/1523-1747.ep12461361. [DOI] [PubMed] [Google Scholar]
  11. Landmann L. The epidermal permeability barrier. Anat Embryol (Berl) 1988;178(1):1–13. doi: 10.1007/BF00305008. [DOI] [PubMed] [Google Scholar]
  12. McCune S. A., Harris R. A. Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis. J Biol Chem. 1979 Oct 25;254(20):10095–10101. [PubMed] [Google Scholar]
  13. Menon G. K., Feingold K. R., Elias P. M. Lamellar body secretory response to barrier disruption. J Invest Dermatol. 1992 Mar;98(3):279–289. doi: 10.1111/1523-1747.ep12497866. [DOI] [PubMed] [Google Scholar]
  14. Menon G. K., Feingold K. R., Mao-Qiang M., Schaude M., Elias P. M. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis. J Invest Dermatol. 1992 Feb;98(2):209–219. doi: 10.1111/1523-1747.ep12555880. [DOI] [PubMed] [Google Scholar]
  15. Menon G. K., Feingold K. R., Moser A. H., Brown B. E., Elias P. M. De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements. J Lipid Res. 1985 Apr;26(4):418–427. [PubMed] [Google Scholar]
  16. Monger D. J., Williams M. L., Feingold K. R., Brown B. E., Elias P. M. Localization of sites of lipid biosynthesis in mammalian epidermis. J Lipid Res. 1988 May;29(5):603–612. [PubMed] [Google Scholar]
  17. Odland G. F., Holbrook K. The lamellar granules of epidermis. Curr Probl Dermatol. 1981;9:29–49. doi: 10.1159/000403343. [DOI] [PubMed] [Google Scholar]
  18. Panek E., Cook G. A., Cornell N. W. Inhibition by 5-(tetradecyloxy)-2-furoic acid of fatty acid and cholesterol synthesis in isolated rat hepatocytes. Lipids. 1977 Oct;12(10):814–818. doi: 10.1007/BF02533270. [DOI] [PubMed] [Google Scholar]
  19. Proksch E., Elias P. M., Feingold K. R. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J Clin Invest. 1990 Mar;85(3):874–882. doi: 10.1172/JCI114514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Prottey C. Essential fatty acids and the skin. Br J Dermatol. 1976 May;94(5):579–585. doi: 10.1111/j.1365-2133.1976.tb05151.x. [DOI] [PubMed] [Google Scholar]
  21. Siegenthaler U., Laine A., Polak L. Studies on contact sensitivity to chromium in the guinea pig. The role of valence in the formation of the antigenic determinant. J Invest Dermatol. 1983 Jan;80(1):44–47. doi: 10.1111/1523-1747.ep12531034. [DOI] [PubMed] [Google Scholar]
  22. Wertz P. W., Downing D. T. Glycolipids in mammalian epidermis: structure and function in the water barrier. Science. 1982 Sep 24;217(4566):1261–1262. doi: 10.1126/science.7112128. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES